Daily Archives: August 15, 2018

Algeco Announces Second Quarter 2018 Financial Results Conference Call and Change to Reporting in Euro

BALTIMORE, Aug. 15, 2018 (GLOBE NEWSWIRE) — Algeco Investments B.V. (together with its subsidiaries, “Algeco”), the leading global business services provider of modular space, secure portable storage solutions and remote workforce accommodations, today announced that it will hold its second quarter 2018 financial results conference call on Wednesday, August 29, 2018 at 10:00 a.m., Eastern Time.

To access the call, please dial (847) 585-4422 or (888) 424-8151 (US toll free) and enter participant PIN code 6638830# approximately ten minutes prior to the start of the call.  You will be placed on hold until the event begins. The conference call will also be broadcast over the internet with an accompanying slide presentation. To join the web conference, go to http://web.meetme.net/r.aspx?p=2&a=UTiLPVrenccJZd. Please enter your name, email address and company to join the call. The customer service team can be reached at any time by pressing *0 on your telephone keypad.

Prior to the call, the slide presentation and second quarter 2018 financial information will be available at http://www.algecoscotsman.com/en/investors.html. Following the call, a recording of the call will also be available.

Additionally, as of the second quarter 2018, we have changed our reporting currency from USD to euros, and to aid investors, we have now posted a version of the first quarter 2018 investor presentation in euros to the investor page of our website.

About Algeco

Algeco is the leading global business services provider focused on modular space, secure portable storage solutions, and remote workforce accommodation management. Headquartered in Baltimore, Algeco has operations in 24 countries with approximately 244,000 modular space and portable storage units and 11,700 remote accommodations rooms. The company operates as Target Logistics in North America, Algeco in Europe, Elliott in the United Kingdom, Ausco in Australia, Portacom in New Zealand, and Algeco Chengdong in China.

Investor Relations Contact

Scott Shaughnessy
Vice President, Finance
Algeco
+1 410-933-5921
Scott.Shaughnessy@willscot.com

Open Society Names New Head of West Africa Foundation

New York, Aug. 15, 2018 (GLOBE NEWSWIRE) — The Open Society Foundations are pleased to announce the appointment of Ayisha Osori as executive director of the Open Society Initiative for West Africa (OSIWA), effective September 4.

Osori is a lawyer, development consultant, and communications strategist with 18 years of experience in both the public and private sectors. She has worked with the World Bank, the United Nations Children’s Fund, the National Democratic Institute, and the Department of International Development on a wide range of issues, such as projects on good governance, gender equality, women’s economic and political empowerment, and ending violence against women. A longtime advocate for women’s rights in Nigeria, she serves on the board of directors of the Nigerian Women Trust Fund.

“I can’t wait to get started,” said Osori. “OSIWA has been at the forefront of civil society’s work across West Africa, and I am thrilled to have the opportunity to help lead its efforts to promote democratic practice, economic advancement, equality, justice, and human rights; and to work with some of the smartest and most committed people in the region and the world.”

A regular commentator on radio and television in the region, Osori wrote a regular column on legal and social issues for such leading Nigerian news outlets as This Day and The Citizen. She is the author of the 2017 book Love Does Not Win Elections, which is about her experiences as a candidate of Nigeria’s Peoples’ Democratic Party in a primary contest for a seat in the country’s National Assembly. She has also written a series of children’s textbooks on social studies used in Nigeria’s primary schools.

A graduate of the University of Lagos and Harvard Law School, Osori is licensed to practice law in Nigeria and New York State. An Eisenhower Fellow, she also holds a Masters in Public Administration from Harvard’s John F. Kennedy School of Government.

Osori begins her new role with a deep knowledge of OSIWA, having served as board chair for the past three years. With Osori’s appointment as executive director, Senegalese scholar, author, and OSIWA board member Felwine Sarr takes over as board chair. Board member Mariama Anthony-Williams, an accountant and public financial management advisor from Sierre Leone, becomes vice chair.

“We are honored to have the leadership of the next chapter of OSIWA’s work in Ayisha Osori’s capable hands,” said Patrick Gaspard, president of the Open Society Foundations. “She has already built an impressive legacy of work on a wide variety of issues of concern to Open Society in the region, and she always puts the advancement of women’s rights at the fore. I look forward to partnering with her to advance our work and our values throughout West Africa.”

OSIWA works in 10 countries throughout the region: Benin, Cote D’Ivoire, Ghana, Guinea, Liberia, Mali, Niger, Nigeria, Sierra Leone, and Senegal. Among other areas of concern, OSIWA has helped to develop civil society’s capacity, improve transparency and public service delivery, and promote good governance. For more on the foundation’s mission and accomplishments, visit www.osiwa.org.

Office of Communications
Open Society Foundations 
(212)-548-0668
media@opensocietyfoundations.org

Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results

– Phase 2 clinical trial initiated to further evaluate NSI-566 as treatment for ischemic stroke –
– NSI-189 Granted Orphan Drug Designation for the Treatment of Angelman Syndrome –
– Jim Scully appointed interim chief executive officer –

GERMANTOWN, Md., Aug. 15, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, provides a business update and reported its financial results for the second quarter ended June 30, 2018.

“We are pleased to report a productive second quarter of 2018 as we continue to advance our pipeline of innovative neural stem cell and small molecule therapies,” said Jim Scully, interim Chief Executive Officer of Neuralstem. “We are especially excited about the advancement of our lead stem cell therapy candidate, NSI-566, into a Phase 2 trial in ischemic stroke, as well as its potential application to other areas of unmet medical need. Additionally, based on encouraging preclinical data, we look forward to exploring our small molecule NSI-189’s potential treatment applications, including Angelman Syndrome and Alzheimer’s Disease.”

Clinical Highlights

NSI-566, is a spinal cord-derived neural stem cell line that is being evaluated to treat paralysis associated with stroke, Amyotrophic Lateral Sclerosis (ALS) and chronic spinal cord injury (cSCI). NSI-566 is Neuralstem’s lead stem cell therapy candidate.

  • In July, Neuralstem announced initiation of a Phase 2 clinical trial evaluating NSI-566 as a potential treatment for ischemic stroke. This trial, which will be a randomized, double-blind, controlled study, is based on the positive results from the open-label Phase 1 safety study and is intended to further test the safety and efficacy of NSI-566 to reverse paralysis in stroke patients where half of their body has been partially paralyzed. James Li, Ph.D., Executive Vice President of Asia Operations of Suzhou Neuralstem Ltd, will be managing this trial which will be taking place at Bayi Brain Hospital in Beijing, China, and commenced on August 1, 2018.  In Phase 1, NSI-566 treatment of 9 chronically hemiparetic stroke patients resulted in statistically significant improvement from baseline of motor functioning and clinical status.
  • In June, the Company announced the results from a study published in Cell Stem Cell that support the potential therapeutic application of transplanted NSI-566 in patients with chronic spinal cord injury (cSCI). The manuscript, entitled “A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury,” presented a detailed analysis of motor and sensory function and electrophysiology results which showed improvement in three of the four patients after NSI-566 transplantation. The study’s primary objective was to evaluate the safety of NSI-566 transplantation in subjects with stable thoracic spinal cord injury, and additional endpoints measured included changes in neurologic deficits, neurophysiology, and neuropathic pain.
  • In May, the Company announced the results from a study published in the Annals of Clinical and Translational Neurology in a manuscript entitled “Long-term Phase 1/2 Intraspinal Stem Cell Transplantation Outcomes in Amyotrophic Lateral Sclerosis” that support the potential of transplanted human spinal cord-derived neural stem cells (HSSC) to stabilize functioning of ALS patients. The study evaluated the impact of HSSC transplantation on functional outcomes, as measured using the ALSFRS-R scale, and on a composite statistic that combined functional and survival outcomes. Results were evaluated against matched controls derived from two historical datasets and showed significantly better ALSFRS-R scores at 24 months, as well as the composite functional/survival score in subjects receiving HSSC. The ALS Functional Rating Scale-Revised (ALSFRS-R) is a validated questionnaire that measures physical function in performing activities of daily living (ADLs).

NSI-189, is a small molecule benzylpiperazine-aminopyridine, in clinical development for MDD and in preclinical development for Angelman syndrome, irradiation-induced cognitive impairment, Type 1 and Type 2 diabetes, and stroke.

  • In August, the Company announced it had been granted orphan drug designation by the FDA for the treatment of Angelman Syndrome.  In pre-clinical models, NSI-189 has demonstrated the ability to restore long term potentiation (LTP), a measure of synaptic plasticity and an in vitro biomarker of memory. Angelman Syndrome (AS) is a rare congenital genetic disorder caused by a lack of function in the UBE3A gene on the maternal 15th chromosome.  It affects approximately one in 15,000 people – about 500,000 individuals globally.  Symptoms of AS include developmental delay, lack of speech, seizures, and walking and balance disorders. Patients with AS may never walk or speak and require life-long care. Life expectancy is normal which places a significant burden on patients and caregivers. There are currently no FDA-approved therapies for the treatment of Angelman syndrome.  The FDA’s orphan-drug designation program provides special status and incentives to encourage the development of drugs for diseases affecting fewer than 200,000 people in the U.S. Orphan drug designation confers seven years of market exclusivity upon FDA approval, as well as other development incentives, such as tax credits related to clinical trial expenses, an exemption from the FDA-user fee and FDA assistance in clinical trial design.
  • In July, the Company presented preclinical data at the Alzheimer’s Association International Conference in Chicago, Illinois, demonstrating that oral administration of NSI-189 in a mouse model of Alzheimer’s Disease leads to a significant amelioration and/or improvement in cognition measures and anxiety. Results were presented in a poster titled ‘Effect of Neurogenic Compound NSI-189 on Indices of Cognition and Anxiety in a Mouse Model (5XFAD) of Alzheimer’s Disease.’ The study was carried out by Dr. Corinne Jolivalt’s laboratory at the University of California, San Diego, and found that treatment with NSI-189 significantly improved learning ability as well as retention, short-term memory and anxiety levels of mice.

Corporate Highlights

  • Effective August 1, Jim Scully was appointed as interim chief executive officer by the Board of Directors. Mr. Scully succeeds Mr. Rich Daly, former Neuralstem president and chief executive officer.  Mr. Scully brings to Neuralstem a wealth of experience from a range of senior executive roles in the pharmaceutical and broader healthcare industry, including leadership roles in financial and strategic planning, global business development and general management at Takeda Pharmaceuticals, Astellas Pharmaceuticals, Abbott Laboratories and Walgreens.
  • Also, effective August 1, the Board of Directors appointed William Oldaker as Chairman of the Board. Mr. Oldaker has served as a director of Neuralstem since April 2007. Additionally, he is a founder and partner in the Washington, D.C. law firm, Oldaker & Willison PLLP, and is a member of the Colorado, D.C. and Iowa Bar Associations, the Bar Association for the Court of Appeals, D.C., and the Bar of the United States Supreme Court.

Financial Results for the Quarter Ended June 30, 2018

Cash Position and Liquidity:  At June 30, 2018, cash and investments was $7.1 million as compared to $9.7 million at March 31, 2018.  The $2.6 million decrease reflects a $0.6 million loss for the period adjusted for certain non-cash items including a $1.4 million gain related to the change in fair value of our liability classified warrants, $760,000 net cash outflows related to changes in operating assets and liabilities, and $200,000 of share-based compensation. The Company expects its existing cash, cash equivalents and short-term investments to fund its operations based on its current operating plans, into the first quarter of 2019.

Operating Loss: Operating loss for the second quarter ended June 30, 2018 was $2.0 million compared to a loss of $4.2 million for the comparable period of 2017.  Operating loss for the six months ended June 30, 2018 was $4.4 million compared to a loss of $8.5 million for comparable period of 2017.

The decrease in operating loss for both the three- and six-month periods was primarily related to decreases in clinical trial and related costs due to the completion of the NSI-189 Phase 2 clinical trial, decreases in personnel, facility and related expenses due to ongoing corporate restructuring and cost reduction efforts offset by revenues from a milestone-based royalty and reimbursements under a National Institute of Health (NIH) grant.

Net Loss:  Net loss for the second quarter ended June 30, 2018 was $0.6 million, or $0.04 per share (basic), compared to a loss of $4.6 million, or $0.39 per share (basic), for the comparable period of 2017.  The decrease in net loss was primarily due to a decrease in operating loss and the non-cash charges related to the change in the fair value of liability classified warrants.

Net loss for the six months ended June 30, 2018 was $2.8 million, or $0.18 per share (basic), compared to a loss of $12.2 million, or $1.06 per share (basic), for the comparable period of 2017.  The decrease in net loss was primarily due to a decrease in operating loss and the non-cash charges related to the change in the fair value of liability classified warrants and warrant inducement expenses in the 2017 period and a decrease in interest expense related to our long-term debt which matured in April 2017.

Research and Development Expenses: The $1.0 million of research and development expenses for the quarter ended June 30, 2018 represents a $1.6 million, or 61% decrease over the comparable period of 2017.  This decrease was primarily attributable to a $710,000 decrease in personnel and facility expenses due to ongoing corporate restructuring and cost reduction efforts, a $310,000 decrease in clinical trial and related costs due to the completion of our NSI-189 Phase 2 clinical trial and a $410,000 decrease in non-cash share-based compensation expense along with $90,000 of reimbursements under a NIH grant.

The $2.2 million of research and development expenses for the six months ended June 30, 2018 represents a $3.3 million, or 60% decrease over the comparable period of 2017.  This decrease was primarily attributable to a $1.8 million decrease in personnel and facility expenses due to ongoing corporate restructuring and cost reduction efforts, a $540,000 decrease in clinical trial and related costs due to the completion of the NSI-189 Phase 2 clinical trial, a $720, 000 decrease in our non-cash share-based compensation expense along with $180,000 of reimbursements under a NIH grant.

General and Administrative Expenses:  The $1.3 million of general and administrative expenses for the second quarter ended June 30, 2018 represents a $380,000, or 23% decrease over the comparable period of 2017.  This decrease was primarily attributable to a $400,000 decrease in payroll and related expenses due to corporate restructuring and cost reduction efforts coupled with a $40,000 decrease in non-cash share-based compensation expense partially offset by a $70,000 increase in tax and insurance expenses.

The $2.4 million of general and administrative expenses for the six months ended June 30, 2018 represents a $530,000, or 18% decrease over the comparable period of 2017.  This decrease was primarily attributable to a $560,000 decrease in payroll and related expenses coupled with a $40,000 decrease in consulting and professional service expenses due to corporate restructuring and cost reduction efforts partially offset by a $90,000 increase in our tax and insurance expenses.

Neuralstem, Inc.
Unaudited Condensed Consolidated Balance Sheets
June 30, December 31,
2018 2017
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 7,092,832 $ 6,674,940
Short-term investments 5,000,000
Trade and other receivables 478,722 312,802
Current portion of related party receivable, net of discount 58,784
Prepaid expenses 343,428 402,273
Total current assets 7,914,982 12,448,799
 
Property and equipment, net 128,017 172,886
Patents, net 814,023 883,462
Related party receivable, net of discount and current portion 343,281 365,456
Other assets 33,004 13,853
Total assets $ 9,233,307 $ 13,884,456
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses $ 713,068 $ 875,065
Accrued bonuses 418,625
Other current liabilities 52,933 220,879
Total current liabilities 766,001 1,514,569
Warrant liabilities 2,283,833 3,852,882
Other long term liabilities 8,270 1,876
Total liabilities 3,058,104 5,369,327
STOCKHOLDERS’ EQUITY
Preferred stock, 7,000,000 shares authorized, $0.01 par value; 1,000,000 shares issued and outstanding at both June 30, 2018 and December 31, 2017 10,000 10,000
Common stock, $0.01 par value; 300,000,000 shares authorized, 15,160,014 shares issued and outstanding at both June 30, 2018 and December 31, 2017 151,600 151,600
Additional paid-in capital 217,485,751 217,050,174
Accumulated other comprehensive income 1,142 2,631
Accumulated deficit (211,473,290 ) (208,699,276 )
Total stockholders’ equity 6,175,203 8,515,129
Total liabilities and stockholders’ equity $ 9,233,307 $ 13,884,456
Neuralstem, Inc.
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
Three Months Ended June 30, Six Months Ended June 30,
2018 2017 2018 2017
Revenues $ 252,500 $ 2,500 $ 255,000 $ 5,000
Operating expenses:
Research and development expenses 1,014,780 2,585,079 2,184,221 5,487,165
General and administrative expenses 1,260,692 1,635,652 2,442,746 2,968,073
Total operating expenses 2,275,472 4,220,731 4,626,967 8,455,238
Operating loss (2,022,972 ) (4,218,231 ) (4,371,967 ) (8,450,238 )
Other income (expense):
Interest income 19,514 14,013 37,263 34,896
Interest expense (772 ) (15,728 ) (2,692 ) (154,460 )
Change in fair value of derivative instruments 1,378,830 (341,611 ) 1,569,049 (3,082,925 )
Fees related to issuance of inducement warrants and other expenses (1,646 ) (87,635 ) (5,667 ) (563,719 )
Total other income (expense) 1,395,926 (430,961 ) 1,597,953 (3,766,208 )
Net loss $ (627,046 ) $ (4,649,192 ) $ (2,774,014 ) $ (12,216,446 )
Net loss per share – basic and diluted $ (0.04 ) $ (0.39 ) $ (0.18 ) $ (1.06 )
Weighted average common shares outstanding – basic and diluted 15,144,243 11,906,334 15,130,666 11,525,730
Comprehensive loss:
Net loss $ (627,046 ) $ (4,649,192 ) $ (2,774,014 ) $ (12,216,446 )
Foreign currency translation adjustment (1,604 ) (384 ) (1,489 ) (555 )
Comprehensive loss $ (628,650 ) $ (4,649,576 ) $ (2,775,503 ) $ (12,217,001 )

Cautionary Statement Regarding Forward Looking Information:

This news release contains “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem’s periodic reports, including its Annual Report on Form 10-K for the year ended December 31, 2017, and its Quarterly Report on Form 10-Q for the three months ended March 31, 2018, filed with the Securities and Exchange Commission (SEC), and in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.

Contact:

Argot Partners (Investor Relations)
212-600-1902
neuralstem@argotpartners.com

Huobi Joins GLASS Network and Invests in SharesPost

Huobi joins network enabling compliant trading of digital securities globally

San Francisco, CA, Aug. 15, 2018 (GLOBE NEWSWIRE) — SharesPost, a leading provider of liquidity solutions to the private growth asset class, has announced that Huobi, China’s largest cryptocurrency and blockchain token exchange and second largest worldwide, has joined the Global Liquidity and Settlement System network (GLASS). When GLASS becomes operational, Huobi will be able to settle secondary trades of digital securities by U.S. investors in compliance with U.S. securities laws. Huobi will also be able to pool its nine million customers’ buy and sell orders with other exchanges using GLASS on a trading pair by trading pair basis.

Greg Brogger, Founder and CEO of SharesPost, said: “We are very excited to see GLASS validated by such a highly respected trading platform. It signals the start of the next stage of development in the digital securities market, and we expect it will go a long way to clearing the cloud that the absence of a legitimate global compliance solution has cast over crypto markets for the last year.”

Originated by SharesPost, GLASS is a decentralized, global network of crypto trading platforms and licensed broker dealers and exchanges. GLASS is designed to be the blockchain community’s shared compliance and settlement infrastructure. Each country will have licensed entities, like SharesPost’s U.S. Alternative Trading System (ATS), on the GLASS network. When trading platforms like Huobi match an offshore client in a digital securities trade, they can submit the trade to the network’s licensed entity in the client’s home jurisdiction for compliant settlement. Huobi joins other prominent centralized and decentralized crypto trading platforms, including OKCoin and Stellar, in supporting the launch of GLASS.

Wang Run, CEO of Huobi Eco, said: “Huobi Eco, acting as the corporate development and strategic investment arm of Huobi, is focusing on developing the ecosystem surrounding Huobi’s main exchange business. Our goal is to provide more efficiency in finance and greater access for the mass population to wealth creation opportunities. Huobi Eco has always been committed to supporting solutions for Huobi to operate within the compliance requirements of every country in which we do business. This is even more important as our market matures. Institutional and other investors who are now becoming active in crypto markets are seeking safe platforms regulated by trusted authorities. Becoming a member of GLASS will provide Huobi a way to serve these customers in every jurisdiction as well as serving as an important milestone for the establishment of the Huobi Global Ecosystem.”

Exchanges on GLASS can also opt to pool their customers’ orders for certain tokens with those of other exchanges. This is meant to provide sufficient liquidity for the anticipated wave of security tokens and tokenized assets and drive incremental trading revenue to member exchanges. Within a month of the launch of GLASS, the aggregated volume of GLASS member exchanges already represents the single largest pool of liquidity for token trading in the world. GLASS member exchanges will benefit from the resulting network effects.

Huobi has also made an equity investment in SharesPost. “We are thrilled to have Huobi as a shareholder,” said Brogger. “Because of Huobi’s proven ability to innovate for their enormous investor base in China and throughout Asia, we can imagine no better partner in our mission to create a compliant, efficient global marketplace for all types of private growth company securities.”

For more information on SharesPost, visit SharesPost.com.

For more information on GLASS, visit Glassnet.io.

For more information on Huobi, visit Huobi.com.

SharesPost Founder and CEO Greg Brogger is available for interview.

About SharesPost:SharesPost’s mission is to create liquidity for the private growth asset class.  In 2009, SharesPost launched the first online secondary market for private technology company shares. Since then, SharesPost has connected thousands of buyers and sellers in more than $4 billion worth of transactions in the shares of more than 220 leading technology companies.

The SharesPost platform now also enables clients to access a variety of private market investment and liquidity solutions including (i) research and data on leading private technology companies, (ii) the SharesPost Private Growth Index, (iii) the SharesPost100 Fund, a registered closed-end interval fund providing all investors with easy access to the asset class, and (iv) SharesPost Lending, which enables private company shareholders to borrow against their shares.  In 2017, SharesPost managed its first Initial Coin Offering and in 2018 announced plans to integrate trading of digital securities into the SharesPost platform.

SharesPost is a FINRA-registered broker-dealer, SEC registered Alternative Trading System and Registered Investment Advisor. For more information, please visit SharesPost.com.

About GLASS:GLASS is a decentralized liquidity and settlement network for crypto trading platforms and exchanges.

Participating exchanges will deepen their liquidity, drive incremental transaction volume and settle compliant token transactions in all jurisdictions irrespective of whether or not the tokens are securities. The GLASS network will be anchored initially by the SharesPost Marketplace, an already established U.S. Alternative Trading System for digital and other unregistered securities. For more information, please visit glassnet.io.

About Huobi:Huobi Group is the leading global blockchain asset financial service provider. With a mission to make investing in alternative assets more efficient and adaptable, the company is committed to providing customers with safe, professional, and honest services based on the core principle of putting the customer first. Established in 2013, Huobi has become one of the world’s largest digital asset exchanges with an accumulated trading volume of US $1 trillion. Having once accounted for half of the world’s digital asset transactions, Huobi now serves more than 5 million users in over 130 countries around the world. With compliance teams in Singapore, the United States, Japan, Korea, Hong Kong, Thailand, Australia and other countries and regions around the world, Huobi is able to provide safe and reliable digital asset trading and management services to its customers. To date, Huobi Group has also invested in more than 40 upstream and downstream companies.

Huobi Global Ecosystem Fund was established in 2018 with the purpose of investing in the best companies and form close partnerships in the blockchain space. Together with our partners, we aim to work together to make the blockchain ecosystem healthier and stronger. For more information, please visit huobi.com.

Amanda Woodward
SharesPost
9179002738
amanda@wachsman.com

Constellation Brands to Invest $5 Billion CAD ($4 Billion USD) in Canopy Growth to Establish Transformative Global Position and Alignment

Expands Strategic Partnership to Accelerate Canopy Growth’s Global Expansion Plans in Rapidly-Growing Medical and Recreational Cannabis Markets

VICTOR, N.Y. and SMITHS FALLS, Ontario, Aug. 15, 2018 (GLOBE NEWSWIRE) — Constellation Brands (NYSE: STZ and STZ.B), a leading beverage alcohol company, and Canopy Growth Corporation (Canopy Growth) (TSX: WEED, NYSE: CGC), a leading diversified cannabis company (together, the “Companies”), today announced a significant expansion of their strategic partnership to position Canopy Growth as the global leader in cannabis production, branding, intellectual property and retailing.

Constellation Brands will increase its ownership interest in Canopy Growth by acquiring 104.5 million shares directly from Canopy Growth, thereby achieving approximately 38 percent ownership when assuming exercise of the existing Constellation warrants.  Constellation Brands is acquiring the new shares at a price of C$48.60 per share, which is a 37.9 percent premium to Canopy’s 5-day volume weighted average price of the common shares on the Toronto Stock Exchange (“VWAP”), and a 51.2 percent premium to the closing price on August 14, 2018.  Constellation will also receive additional warrants of Canopy that, if exercised, would provide for at least an additional $4.5 billion CAD to Canopy Growth.

As a result of the new shares Constellation is acquiring, Canopy Growth will immediately upon closing have proceeds of approximately $5 billion CAD ($4 billion USD) to bolster its leadership position in the global cannabis industry.  This investment, the largest to date in the cannabis space, will provide funds which Canopy Growth will deploy to strategically build and/or acquire key assets needed to establish global scale in the nearly 30 countries pursuing a federally permissible medical cannabis program, while also rapidly laying the global foundation needed for new recreational cannabis markets.  Canopy Growth’s Canadian platform does not require additional cannabis cultivation assets, and management views other jurisdictions, including the United States, as strategic priorities requiring significant capital.

“Through this investment, we are selecting Canopy Growth as our exclusive global cannabis partner,” said Rob Sands, Chief Executive Officer, Constellation Brands.  “Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space.  We look forward to supporting Canopy as they extend their recognized global leadership position in the medical and recreational cannabis space.”

Canopy Growth will benefit from Constellation’s deep understanding of consumer trends and shifting preferences, and proven ability to translate those insights into distinct brand positionings that build strong connections with consumers and foster brand loyalty.  Constellation’s disciplined approach and capabilities in areas such as mergers and acquisitions, finance, large-scale production, marketing and sales as a leading Fortune 500 company, combined with Canopy’s entrepreneurial approach and best-in-class knowledge and expertise within the emerging cannabis sector create a powerful combination that will ensure Canopy Growth is set up for sustainable, long-term success as the company and sector evolve.

Founded in 2013, Canopy Growth has cemented itself as the industry leader in Canada’s legal cannabis market.  Through its subsidiaries Tweed and Spectrum Cannabis, Canopy Growth has established a global presence in 11 countries which is driven by product innovation, a robust intellectual property portfolio, and clinical research programs targeting both human and animal health.  In Canada, Canopy Growth has established sophisticated operations to support recreational sales by raising capital and making the strategic investments required to maintain and accelerate its market leadership position at a critical time in the company’s evolution.  Substantial capital is required to fully capitalize on Canopy Growth’s market-leading position in Canada and establish similar leading positions in markets around the globe.

“Our business can now make the strategic investments required to accelerate our market position globally,” said Bruce Linton, Chairman and Co-CEO, Canopy Growth.  “Constellation’s concentration of global cannabis activities exclusively through Canopy, coupled with the investment and its expert capabilities in brand-building, marketing, consumer insights and M&A will be a huge benefit as we look to expand our portfolio in Canada, the United States and emerging cannabis markets around the globe.  We view this investment in our business as an endorsement of our execution since forming our initial strategic relationship in October 2017.”

As part of the proposed transaction, Constellation will nominate four directors to Canopy Growth’s seven-member Board of Directors, Chaired by Founder Bruce Linton.  Canopy Growth will remain a proudly Canadian publicly-traded company headquartered in Smiths Falls, Ontario, Canada and will continue to be led by its existing management team, who will continue to manage all international cannabis operations.

As part of its investment, Constellation is receiving 139.7 million new warrants which are exercisable over the next 3 years.  Of those, 88.5 million are exercisable at a price per share of C$50.40, a 43.0 percent premium to Canopy’s VWAP, and 51.3 million are exercisable at the VWAP at the time of exercise.  If Constellation were to exercise all existing and new warrants, its ownership would exceed 50 percent.

Canopy Growth’s future plans include pursuing various product formats in all cannabis channels.  Both companies have no plans to sell cannabis products in any market unless it is permissible to do so at all applicable government levels.  Canopy Growth remains committed to not entering the U.S. market in any manner that would contravene U.S. federal laws.

Constellation expects to account for its investment under the equity accounting method.  As such, the transaction is expected to be accretive to the company’s full year diluted earnings per share in fiscal 2021.  In addition, Constellation Brands remains committed to its investment grade rating and therefore, has no plans to engage in mergers, acquisitions or share repurchase activity until the company returns to its 3.5x leverage target, which is expected to occur within 18-24 months of deal closing.

The transaction is subject to customary closing conditions, including Canopy shareholder approval and applicable Canadian government and regulatory approvals, and is expected to close by the end of October 2018.  Goldman Sachs advised Constellation Brands and Bank of America Merrill Lynch is providing committed financing for this transaction.  Greenhill & Co. Canada Ltd. acted as exclusive financial advisor to Canopy Growth.  Kingsdale Advisors is acting as strategic shareholder communications advisor and proxy solicitation agent to Canopy Growth.

Canopy Growth shareholders should contact Kingsdale Advisors at 1-877-657-5857. Or collect outside North America at 1-416-867-2272, or by email at contactus@kingsdaleadvisors.com.

Canopy Growth Chairman and Co-CEO Bruce Linton and Constellation Brands CEO Rob Sands will provide further commentary on this expanded partnership at the beginning of Canopy Growth’s earnings call to be held today at 8am Eastern Time.

Webcast Information:
A live audio webcast will be available at:
https://event.on24.com/wcc/r/1800764/F7B6A3CFF26AED5C28B555A658CF1105 

Calling Information:
Toll Free Dial-In Number: 1-888-231-8191
International Dial-In Number: (647) 427-7450
Conference ID: 4984819

Replay Information:
A replay of the call will be accessible by telephone until 11:59 PM ET on November 13, 2018.
Toll Free Dial-in Number: 1-855-859-2056
Replay Password: 4984819

About Constellation Brands
Constellation Brands (NYSE: STZ and STZ.B), a Fortune 500® company, is a leading international producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. Constellation is the No. 3 beer company in the U.S. with high-end, iconic imported brands such as Corona Extra, Corona Light, Modelo Especial, Modelo Negra and Pacifico. The company’s beer portfolio also includes Ballast Point, one of the most awarded craft brewers in the U.S., and Funky Buddha Brewery. In addition, Constellation is the world leader in premium wine, selling great brands that people love, including Robert Mondavi, Clos du Bois, Kim Crawford, Meiomi, Mark West, Black Box, Ruffino and The Prisoner. The company’s premium spirits brands include SVEDKA Vodka, Casa Noble Tequila and High West Whiskey.

Based in Victor, N.Y., the company believes that industry leadership involves a commitment to brand building, our trade partners, the environment, our investors and to consumers around the world who choose our products when celebrating big moments or enjoying quiet ones. Founded in 1945, Constellation has grown to become a significant player in the beverage alcohol industry with more than 100 brands in its portfolio; about 40 wineries, breweries and distilleries; and approximately 10,000 talented employees. We express our company vision: to elevate life with every glass raised. To learn more, follow us on Twitter @cbrands and visit www.cbrands.com.

About Canopy Growth Corporation
Canopy Growth (TSX: WEED) is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly-owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public’s understanding of cannabis. For more information visit www.canopygrowth.com.

Forward-Looking Statements
This news release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements. The words “expect,” “intend” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements may relate to business strategy, future operations, prospects, plans and objectives of management, as well as information concerning expected actions of third parties. All forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements. The forward-looking statements are based on management’s current expectations and should not be construed in any manner as a guarantee that such results will in fact occur or will occur on the timetable contemplated hereby. Examples of such statements include but are not limited to the timing and completion of the proposed transaction, shareholder approval, and applicable government and regulatory approvals of the proposed transaction, anticipated use of proceeds, exercise by Constellation Brands of any warrants, expected accounting method, future expansion efforts, the leadership of Canopy Growth in the cannabis industry, the impact of the transaction on Canopy Growth’s market position, the composition of Canopy Growth’s management team, the location of Canopy Growth’s headquarters, future operational and production capacity and requirements, the impact of any enhanced infrastructure and production capabilities, future success and anticipated available product selection. All forward-looking statements speak only as of the date of this news release and neither Constellation Brands nor Canopy Growth undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition to risks and uncertainties associated with ordinary business operations, the forward-looking statements contained in this news release are subject to other risks and uncertainties, including completion of the announced transaction; the accuracy of all projections; the exact elements of Constellation Brands’ permanent financing will depend upon market conditions; Constellation’s ability to achieve expected and target debt leverage ratios and the timeframe in which the debt leverage ratio will be achieved will depend upon actual financial performance; circumstances may warrant that Canopy Growth use the proceeds from the transaction for different purposes than stated above; the expected benefits of the transaction may not materialize in the manner or timeframe expected, or at all; and other factors and uncertainties disclosed from time-to-time in Constellation Brands, Inc.’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended February 28, 2018 or in Canopy Growth’s filings with the Canadian Securities Administration or with the United States Securities Exchange Commission, including its annual information form dated June 28, 2018, which could cause actual future performance to differ from current expectations.

CONTACTS:
Michael McGrew, Constellation Brands, Media (773) 251-4934
Patty Yahn-Urlaub, Constellation Brands, Investor Relations (585) 678-7483
Jordan Sinclair, Canopy Growth, Media (613) 769-4196
Tyler Burns, Canopy Growth, Investor Relations (855) 558-9333 ext. 122

ATPCO ได้รับสิทธิบัตรสำหรับโมเดลการกำหนดราคาตั๋วเครื่องบินแบบไม่ใช้แคช (Cache)

สร้างเทคโนโลยีที่เป็นพื้นฐานสำหรับเครื่องมือบริหารจัดการรายได้สายการบินแบบ Next-Gen

DULLES, Va., Aug. 15, 2018 (GLOBE NEWSWIRE) — วันนี้ ATPCO ได้ประกาศเกี่ยวกับการที่ได้รับสิทธิบัตร #10,032,195 สำหรับเทคโนโลยีใหม่จากสำนักงานสิทธิบัตรและเครื่องหมายการค้าแห่งสหรัฐฯ ซึ่งเทคโนโลยีนี้ได้พัฒนาขึ้นโดยนักวิทยาศาสตร์ข้อมูลและสถาปนิกด้านเทคนิคของ ATPCO ซึ่งช่วยให้สามารถกำหนดราคาตั๋วเครื่องบินโดยใช้ฐานข้อมูลแบบกราฟ และเทคนิค “การเขียนโปรแกรมเชิงฟังก์ชัน” เทคโนโลยีช่วยให้มีวิธีการเฉพาะในการคำนวณราคาตั๋วเครื่องบินที่ไม่เคยปรากฏมาก่อน

ราคาตั๋วเครื่องบินได้สร้างขึ้นโดยการใช้องค์ประกอบข้อมูลที่หลากหลาย ได้แก่ ค่าโดยสาร ตารางการบิน ภาษี และโครงสร้างทางกฎหมาย และการกำกับดูแลต่างๆ สายการบินแต่ละรายยังกำหนดข้อจำกัดทางธุรกิจ หรือที่เรียกว่ากฎเกณฑ์ เพื่อพิจารณาการเสนอราคาค่าโดยสารในแต่ละกรณี เช่นการขอให้มีการเข้าพักในคืนวันเสาร์หรือในช่วงวันที่ทำการส่งเสริมการขายที่กำหนดไว้ล่วงหน้า โดยองค์ประกอบทั้งหมดเหล่านี้ต้องมีการพิจารณาและรวมอยู่ในราคาขั้นสุดท้ายของตั๋วเครื่องบิน วิธีการกำหนดราคาที่ครอบคลุมด้วยสิทธิบัตรนี้ช่วยให้ ATPCO สามารถกำหนดราคาที่ประกาศไปทั่วโลกในเวลาจริงโดยไม่ขึ้นอยู่กับความพร้อมใช้งาน ซึ่งจะช่วยให้ผู้ให้บริการและคู่ค้าของสายการบินเห็นภาพรวมของราคาทั้งหมดที่สร้างขึ้นในตลาด

John Murphy รองประธานฝ่ายเทคโนโลยี บริษัท ATPCO กล่าวว่า “วิธีการนี้รักษาการเชื่อมโยงทั้งหมดไปยังองค์ประกอบของข้อมูลตั้งต้นที่กำหนดราคาตั๋วเครื่องบินรวม ดังนั้น เราสามารถแยกแยะราคาลงในองค์ประกอบทั้งหมดหลังจากที่สร้างขึ้น รวมทั้งระบุกฎเกณฑ์ทั้งหมดที่ทำให้ราคานั้นเป็นราคามาตรฐาน ซึ่งจะเป็นข้อได้เปรียบอย่างมากสำหรับความสามารถในการกำหนดราคาและการตรวจสอบที่เรากำลังดำเนินอยู่”

ซึ่งแตกต่างจากเครื่องมือการกำหนดราคาแบบดั้งเดิมที่ใช้ในปัจจุบันเพื่อจำหน่ายตั๋วที่มุ่งเน้นการคำนวณราคาต่ำสุดหรือ “ดีที่สุด” ในตลาด แนวทางของ ATPCO ได้รับการออกแบบมาเพื่อสนับสนุนการจัดการรายได้ของสายการบินและฝ่ายกำหนดราคาที่ควบคุมระดับราคาต่างๆ ที่ สายการบินต้องการนำเสนอ

Navid Abbassi หัวหน้าสถาปนิก ATPCO กล่าวว่า “เพื่อสนับสนุนความต้องการดังกล่าว เครื่องมือกำหนดราคาต้องคำนวณราคาสำหรับค่าโดยสารทั้งหมดที่เป็นไปได้ (ไม่ใช่เพียงต่ำสุดเท่านั้น) และติดตามองค์ประกอบทั้งหมดที่สร้างขึ้นโดยไม่ต้องอาศัยผลแคช ผลแคชอาจกลายเป็นล้าสมัยไปได้อย่างรวดเร็วซึ่งจะเป็นปัญหาเมื่อนักวิเคราะห์ราคาของสายการบินต้องการเปลี่ยนแปลงหรือตรวจสอบรูปแบบหรือเหตุผลที่ราคาใดราคาหนึ่งมีการสร้างขึ้น”

เทคโนโลยีนี้ช่วยให้มีการตรวจสอบเมื่อองค์ประกอบเปลี่ยนไป การทดสอบว่าราคาจะเป็นอย่างไร และการตรวจสอบค่าโดยสารก่อนที่จะมีการแจกจ่าย ซึ่งเป็นส่วนหนึ่งของความมุ่งมั่นของ ATPCO ในการนำอุตสาหกรรมการบินสู่ยุคแห่งการกระจายที่ทันสมัยมากขึ้

ด้วยความเร็วและความสามารถในการปรับขยายของวิธีการที่ใช้เทคโนโลยีนี้ เราสามารถสร้างและประมวลผลการตอบสนองต่อการกำหนดราคาจำนวนนับล้านตามเวลาจริง โดยไม่สูญเสียบริบทของข้อมูลที่สร้างราคาเหล่านั้นในตอนแรก ด้วยการเปลี่ยนองค์ประกอบของราคาตั๋วที่ง่ายขึ้นATPCO ได้ให้บริการสายการบินต่างๆ ด้วยวิธีการที่ใหม่และมีประสิทธิภาพมากขึ้นในการจัดการระดับราคาที่สายการบินเหล่านี้สามรถเสนอในตลาดใดก็ได้

ติดตาม ATPCO:
LinkedIn
Twitter
Facebook

หากต้องการข้อมูลเพิ่มเติม สามารถติดต่อ:
Michael Mazzocco
ผู้เชี่ยวชาญด้านกลยุทธ์การสื่อสารองค์กร
ATPCO
สำนักงาน: +1 703 661 7503
อิเมล: mmazzocco@atpco.net

เกี่ยวกับ ATPCO

วางตัวเป็นศูนย์กลางของระบบการจัดจำหน่ายตั๋วเครื่องบินอย่างที่ไม่มีผู้ทำได้มาก่อน ATPCO ช่วยให้สามารถบริหารจัดการข้อมูลตั๋วเครื่องบินได้อย่างคล่องตัว ทำให้อุตสาหกรรมของเราทำงานได้อย่างมีประสิทธิภาพมากยิ่งขึ้น เราถือครองค่าโดยสารมากกว่า 189.6 ล้านรายการให้กับสายการบิน กว่า 439 รายใน 160 ประเทศ และรองรับการเปลี่ยนแปลงค่าโดยสารเฉลี่ย 5.3 ล้านรายการต่อวัน เนื่องจาก ATPCO เป็นเจ้าของโดยสายการบินต่างๆ สายการบินเหล่านั้นจึงเป็นคู่ค้าที่เป็นกลาง และเชื่อถือได้สำหรับสายการบิน ตัวแทนด้านการท่องเที่ยว โปรแกรมค้นหา ระบบการจัดจำหน่าย ระดับโลก และรัฐบาลต่างๆ ทั่วโลก ทุกๆ วัน องค์การเหล่านี้ต้องพึ่งพาความสามารถด้านเทคโนโลยี และโซลูชั่นด้านข้อมูลของ ATPCO เพื่อช่วยให้นักท่องเที่ยวนับล้านๆ รายเดินทางไปยังสถานที่ ที่ต้องการ เรียนรู้เพิ่มเติมที่ atpco.net

2018 Online Journalism Awards finalists and James Foley Award recipient announced

WASHINGTON, Aug. 14, 2018 (GLOBE NEWSWIRE) — Finalists for the 2018 Online Journalism Awards, representing a wide range of local and international media, nonprofit, public, academic and emerging technology organizations, were announced today by the Online News Association.

Thirteen of the awards come with $58,500 in prize money, courtesy of John S. and James L. Knight Foundation, the Gannett Foundation, the University of Florida College of Journalism and Communications and Journalism 360. These awards honor data journalism, visual digital storytelling, investigative journalism, immersive storytelling, public service, technical innovation, student journalism and general excellence.

This year’s awards introduced a new category for Excellence in Collaboration and Partnerships, honoring newsrooms and companies who formed innovative partnerships or collaborations to cover a topic or story with a digital focus. In addition, the General Excellence category now has a micro size group for newsrooms with 15 or fewer employees, thanks to the support of the Democracy Fund.

A special selection committee also granted the James Foley Award for Conflict Reporting to photojournalist Nicole Tung. She is the fourth recipient of the award, which honors journalists reporting under the most challenging conditions. Tung has covered social and conflict-related issues in the Middle East, Asia and Africa, including the conflicts in Libya and Syria, violence against women in Turkey and the pro-democracy protests in Hong Kong.

“The selection committee was impressed by the power and variety of imagery Nicole has captured in conflict zones on multiple continents, and by her consistent focus on the humanity of her subjects,” said Eric Carvin, Social Media Editor at The Associated Press and chair of the selection committee. “Importantly, she’s also been deeply involved in advocating for freelancer rights and safety, and has skillfully used her social presence to both bring attention to those issues and showcase her powerful visual journalism. Nicole knew Jim Foley well, and has been committed to carrying his legacy forward. We’re proud and humbled to celebrate her stunning work, as well as her dedication to the well-being of journalists toiling under the most challenging of circumstances.”

The 2018 winners — including winners of the Rich Jaroslovsky Founder Award and the new ONA Community Award — will be announced at the Online News Association Conference and Online Journalism Awards Banquet on Saturday, Sept. 15, in Austin, Texas.

A group of 132 industry-leading journalists and new media professionals teamed up to screen 1,138 entries and select semi-finalists. More than 25 judges representing a diverse cross-section of the industry then conferred to determine finalists and winners.

The finalists are:

Breaking News, Small Newsroom

  • Austin Serial Bombings, KUT Austin

Breaking News, Medium Newsroom

  • Collapse of the Florida International University Bridge, Miami Herald
  • Wine Country Wildfires, San Francisco Chronicle / Hearst
  • Thomas Fire Coverage, KPCC Southern California Public Radio

Breaking News, Large Newsroom

  • The Search Operation of the Submarine ARA San Juan, LA NACION
  • The Vegas Massacre, The New York Times
  • Horror on Yonge Street, Toronto Star

Explanatory Reporting, Small Newsroom

  • Three Rivers Rising, PublicSource
  • Nuclear Negligence, The Center for Public Integrity
  • Texas Tribune: Dangerous Deliveries, The Texas Tribune

Explanatory Reporting, Medium Newsroom

  • Dirty Gold, Clean Cash, Miami Herald
  • Walking While Black, Florida-Union Times and ProPublica
  • Project Nora, The Oregonian / OregonLive

Explanatory Reporting, Large Newsroom

  • California’s Power Glut, Los Angeles Times
  • The Wall, The Arizona Republic / USA TODAY NETWORK
  • Boston. Racism. Image. Reality., The Boston Globe
  • North Korea, The Washington Post

Online Commentary

  • Seven Steps to Save 27,000 Lives, The Boston Globe
  • Nicholas Kristof and Colleagues, The New York Times

Sports, Small/Medium Newsroom

  • No finalists

Sports, Large Newsroom

  • Eight Seconds: The Life and Death of a Cowboy, The Globe and Mail
  • Olympics, The Globe and Mail
  • The Winter Olympics, The New York Times

Feature, Small Newsroom

  • Californians: Here’s Why Your Housing Costs Are So High, CALmatters
  • Hot Spots, Ensia
  • First Nations Housing, The Discourse
  • LR9LIVE: Making Civil Rights History Come Alive, Youth Radio

Feature, Medium Newsroom

  • Europe Slams Its Gates, Pulitzer Center on Crisis Reporting / Foreign Policy
  • Marshall Islands: The Poison and the Tomb, Mashable
  • Project Nora, The Oregonian / OregonLive

Feature, Large Newsroom

  • Betrayed: Chicago schools fail to protect students from sexual abuse and assault, leaving lasting damage, Chicago Tribune
  • A Betrayal, ProPublica and New York Magazine
  • The Road, The Globe and Mail
  • The Next Edition, The Washington Post

The David Teeuwen Student Journalism Award, Small Newsroom

  • Alone, University of California, Berkeley
  • Justice For Who?, University of California, Berkeley
  • Leaving Tracks: The Capture of Wolf No. 1553, Walter Cronkite School of Journalism and Mass Communication (Arizona State University)

The David Teeuwen Student Journalism Award, Large Newsroom

  • The Deported: Life Beyond the Border, JOVRNALISM / University of Southern California Annenberg School for Communication and Journalism
  • The Perfect Storm, The Eagle / American University
  • Aftermath, UNC School of Media and Journalism

Pro-Am Student Award

  • More Than a Mascot, Philip Merrill College of Journalism and Capital News Service
  • HEI6MAN EVOLUTION, University of Oklahoma and The OU Daily
  • Troubled Water, Walter Cronkite School of Journalism and Mass Communication (Arizona State University) and Carnegie-Knight News21

The University of Florida Award for Investigative Data Journalism, Small/Medium Newsroom

  • Too Broke for Bankruptcy, ProPublica
  • Walking While Black, Florida Times-Union and ProPublica
  • The Taking, The Texas Tribune and ProPublica

The University of Florida Award for Investigative Data Journalism, Large Newsroom

  • Death & Dysfunction, NJ Advance Media
  • Bussed Out: How America Moves its Homeless, The Guardian US
  • The Follower Factory, The New York Times
  • The Number of Students Who Have Experienced Gun Violence at School Since Columbine, The Washington Post

Excellence in Immersive Storytelling

  • Yemen’s Skies of Terror, Contrast VR and Al Jazeera
  • Augmented Reality: David Bowie in Three Dimensions, The New York Times

Excellence in Audio Digital Storytelling, Small Newsroom

  • Bundyville, Longreads and Oregon Public Broadcasting
  • The New American Songbook, The GroundTruth Project
  • She Says, WFAE – Charlotte’s NPR News Source

Excellence in Audio Digital Storytelling, Medium/Large Newsroom

  • Strange Bird: Experimental Podcast and Player, Guardian Mobile Innovation Lab
  • Prosecutor Nisman Phone Interceptions Mapped in Playlists, LA NACION
  • Repeat, KPCC Southern California Public Radio
  • In Harvey’s Wake, The Texas Tribune and Reveal from the Center for Investigative Reporting
  • The Wall Street Journal’s Innovation in Audio Storytelling, The Wall Street Journal

Excellence and Innovation in Visual Digital Storytelling, Small Newsroom

  • The Last Generation, FRONTLINE and The GroundTruth Project
  • Gerda, KUER’s RadioWest

Excellence and Innovation in Visual Digital Storytelling, Medium Newsroom

  • No finalists

Excellence and Innovation in Visual Digital Storytelling, Large Newsroom

  • The Uber Game, The Financial Times
  • Thousands Cried for Help as Houston Flooded, The New York Times
  • The Four Days In 1968 That Reshaped D.C., The Washington Post
  • The Waiting Game, WNYC and ProPublica

Excellence in Collaboration and Partnerships

  • Verificado 2018, AJ+ Español, Animal Político and Pop-Up Newsroom
  • Paradise Papers: Secrets of the Global Elite, International Consortium of Investigative Journalists, Süddeutsche Zeitung, The New York Times, The Guardian and more than 90 other media partners
  • Crossing the Divide, The GroundTruth Project and WGBH Boston

Gannett Foundation Award for Technical Innovation in the Service of Digital Journalism

  • Washington Post ARC Publishing, The Washington Post
  • Trint, Trint

The Al Neuharth Innovation in Investigative Journalism Award, Small Newsroom

  • The Daphne Project, Forbidden Stories
  • Digging into the Mining Arc, InfoAmazonia and Correo del Caroní
  • A Broken System, Injustice Watch

The Al Neuharth Innovation in Investigative Journalism Award, Medium Newsroom

  • “On the Fire Line,” an Investigation Into Rape, Harassment and Retaliation in the U.S. Forest Service, PBS NewsHour
  • Bombs In Our Backyard, ProPublica
  • Trump Town, ProPublica
  • Benefit of the Doubt, The Oregonian / OregonLive

The Al Neuharth Innovation in Investigative Journalism Award, Large Newsroom

  • From Russia With Blood, BuzzFeed News
  • Betrayed: Chicago Schools Fail to Protect Students from Sexual Abuse and Assault, Leaving Lasting Damage, Chicago Tribune
  • Toxic City: Sick Schools, Philadelphia Media Network
  • The Neglected Bridges, VG

Knight Award for Public Service

  • Taking Cover: How Cops Escape Discipline for Shootings in Suburban Chicago, Better Government Association, WBEZ
  • Lost Mothers, ProPublica and NPR
  • All Work. No Pay., Reveal from The Center for Investigative Reporting
  • Hacking Democracy, The Washington Post

General Excellence in Online Journalism, Micro Newsroom

  • Postdata.club
  • PublicSource
  • The New Food Economy
  • The Trace

General Excellence in Online Journalism, Small Newsroom

  • Longreads
  • The Marshall Project
  • The Texas Tribune

General Excellence in Online Journalism, Medium Newsroom

  • Austin American-Statesman
  • ProPublica
  • Quartz
  • Reveal from The Center for Investigative Reporting

General Excellence in Online Journalism, Large Newsroom

  • The New York Times
  • The Washington Post
  • Vox.com

The judges for finalists were:

Laura Amico, Senior Editor, Harvard Business Review
Heather Bryant, Founder, Project Facet
Audrey Cerdan, New Formats Editor, L’Obs
Florencia Coehlo, New Media Research & Trainer, LA NACION
Eva Constantaras, Data Journalist, Data Nomads LLC
Meghann Farnsworth, Director of Social Media, WIRED
Tiffany Fehr, Assistant Editor, Interactive Desk, The New York Times
Kim Fox, Managing Editor, Audience, The Philadelphia Inquirer
Ann Grimes, Associate Director, Brown Institute for Media Innovation, Stanford University School of Engineering
Robert Hernandez, Associate Professor of Professional Practice, USC Annenberg
Rafael Höhr, News Graphic Editor, Prodigioso Volcán
Rich Jaroslovsky, Vice President for Content & Chief Journalist, SmartNews
S. Mitra Kalita, Senior Vice President, News, Opinion & Programming, CNN Digital
Damon Kiesow, Knight Chair in Digital Editing and Producing, Missouri School of Journalism
Celeste LeCompte, Vice President, Business Development, ProPublica
Marian Liu, Communications Manager, JL Audio, Freelancer, CNN Diversity Fellow
Jacqui Maher, Freelance Journalist, Australia
Nathalie Malinarich, Editor, Mobile & New Formats, BBC Mobile and Online
Rebekah Monson, Co-founder and COO, WhereBy.Us
Kate Myers, Executive Director, Revenue and Operations, First Look Media
Núria Net, Managing Editor, Radio Gladys Palmera
Angela Pacienza, Head of Experience, The Globe and Mail
Miguel Paz, Professor, CUNY Journalism School; Founder of Poderopedia
Eliana Vaca, Dataviz Trainer and Creative Director, Chicas Poderosas
Hannah Wise, Engagement Editor, The Dallas Morning News
Anita Zielina, Digital Media Strategy

*Judges were recused from discussing categories in which their own organizations were entered.

Launched in 2000, the OJAs are the only comprehensive set of journalism prizes honoring excellence in digital journalism.

About ONA
The Online News Association is the world’s largest association of online journalists. ONA’s mission is to inspire innovation and excellence among journalists to better serve the public. The membership includes news writers, producers, designers, editors, bloggers, technologists, photographers, academics, students and others who produce and distribute news for digital delivery systems. ONA hosts the annual Online News Association annual conference and administers the Online Journalism Awards.

About Knight Foundation
Knight Foundation is a national foundation with strong local roots. We invest in journalism, in the arts, and in the success of cities where brothers John S. and James L. Knight once published newspapers. Our goal is to foster informed and engaged communities, which we believe are essential for a healthy democracy. For more, visit knightfoundation.org.

About the Gannett Foundation
The Gannett Foundation is a corporate foundation sponsored by Gannett Co., Inc. whose mission is to invest in the future of the communities in which Gannett does business, and in the future of our industry. It supports projects that take a creative approach to fundamental issues such as education and neighborhood improvement, economic development, youth development, community problem-solving, assistance to disadvantaged people, environmental conservation and cultural enrichment.

About the University of Florida College of Journalism and Communications
The University of Florida College of Journalism and Communications is driving innovation and engagement across the disciplines of advertising, journalism, public relations and telecommunication. The strength of its programs, faculty, students and alumni — in research and in practice — has earned the college ongoing recognition as one of the best in the nation among its peers. The college offers bachelor’s, master’s and doctoral degrees and certificates, both online and on campus. The college’s strength is drawn from both academic rigor and experiential learning. The college includes seven broadcast and digital media properties and the nation’s only chair in public interest communications.

About Journalism 360
Journalism 360 is a global network of storytellers accelerating the understanding and production of immersive journalism. Our mission is to help news organizations, journalists, technologists, content creators and journalism educators experiment with all forms of immersive storytelling, including but not limited to 360 video, augmented reality, virtual reality and mixed reality. Its founding partners are the Knight Foundation, Google News Initiative and the Online News Association.

About Democracy Fund
The Democracy Fund invests in social entrepreneurs working to ensure that our political system is responsive to the public and able to meet the greatest challenges facing our nation. To learn more visit DemocracyFund.org.

Contact: Karolle Rabarison, karolle@journalists.org